PIIPAR RIVERA: Open Payments
NPI 1275658007 · FULSHEAR, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$853 in 53 payments from 12 companies in 2025. Trend: 2023 $1,504 · 2024 $2,383 · 2025 $853
Food & beverage: $753Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $231 |
| Galderma Laboratories, L.P. | 9 | $146 |
| Janssen Biotech, Inc. | 1 | $100 |
| Organon LLC | 8 | $81 |
| Regeneron Healthcare Solutions, Inc. | 3 | $73 |
| Amgen Inc. | 3 | $60 |
| GENZYME CORPORATION | 1 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $29 |
| Lilly USA, LLC | 1 | $23 |
Products named: NEMLUVIO, DUPIXENT, SKYRIZI, TREMFYA, RINVOQ, OTEZLA, BOTOX, Sotyktu.
Industry payments across TX — which companies pay providers there.
